The Oncologists at WSU are looking for dogs with lymphoma either untreated, or resistant to standard chemotherapy. A clinical trial to test the efficacy of an in vivo chemotherapy assay is being offered.

The Oncologists at WSU are looking for dogs with masses in need of surgical removal to test new product called “Tumor Paint”. This product paints the margins of tumor while in the patient, to allow for more accurate surgical removal.

http://www.vetmed.wsu.edu/researchVCS/clinicalStudies.aspx

Wednesday, April 18, 2012, 6 PM (Pacific Time) By Web Conference
Webinar by Dr William Dernell

Advanced and severe disease pathology affecting the extremities in small animals often brings the veterinary clinician to the point of considering limb amputation for either cure or palliation.  Because amputation is often a difficult decision for animal owners and because, in some cases, other circumstances result in amputation being contraindicated, knowledge of limb salvage options is important for therapy recommendations and decisions.  This presentation will discuss the indications for, applications of and potential complications of recent advances in limb salvage techniques for veterinary patients.  Although many practicing veterinarians may not perform these more advanced treatments directly, knowledge of their potential application and the important aspects of follow up care can greatly benefit their patients and clients. 

One hour, one CE Credit

 

The WSU Linear accelerator is back up and running at full capacity and treatments are now underway.  Please be patient as we try to accommodate the back log after the 2 month down time.  We hope to better serve the veterinary patients of the Pacific Northwest with our improved equipment and improved treatment planning.

WSU is seeking dogs with bone cancer (osteosarcoma) for possible inclusion in a clinical drug trial to study the Effects of Anti-Angiogenic Chemotherapy
http://bit.ly/dbFA9V

A new treatment study for dogs with lymphoma begins at WSU in June.  To learn more about the clinical trial or find out if your dog is eligible for the study visit http://www.vetmed.wsu.edu/researchVCS/Artemisinin.aspx

The WSU Linear accelerator is shutting down on May 6, 2010 for approximately 2 months while a newer model with greater capabilities is being installed.

Please don't hesitate to contact the clinicians of the oncology service during the down time as we may be able to offer advice on alternate treatments or alternate places where radiation therapy can be performed. 

Please see this page for updates on this project.

Dr. Stephen Withrow, a Professor of Surgical Oncology and Director of the Animal Cancer Center at Colorado State University was the 2010 recipient of the prestigious McCoy Award from WSU College of Veterinary Medicine.  http://bit.ly/cNGdrG

Washington State University’s College of Veterinary Medicine administered a first-of-its-kind cancer treatment, Quadramet, to Cassie,  an 8 year-old, golden retriever with a tumor on her skull in August 2009.  Details

See the October 23, 2009 follow-up video from KHQ News

PULLMAN, Wash.—Washington State University’s College of Veterinary Medicine is administering a first-of-its-kind cancer treatment today to an 8 year-old, golden retriever named “Cassie.”  The drug is known by the generic name Samarium-153-EDTMP or by the brand name of Quadramet.  It works by attaching itself to areas where bone is rapidly growing.  Because a radioactive element is attached to the drug, when the drug binds to the bony tumor, the nuclear energy is localized where it is needed. http://www.vetmed.wsu.edu/news/Cassie.aspx